Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.57 USD | -2.97% | -10.22% | -32.77% |
09/04 | Synaptogenix, Inc. acquired Unknown Stake in Psyga Bio Ltd from Cannasoul Analytics Ltd. | CI |
03/04 | Synaptogenix Plans 1-for-25 Reverse Stock Split; Shares Fall | MT |
Business Summary
Number of employees: 5
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 01/18/01 |
Daniel Alkon
PSD | President | 81 | 07/20/07 |
Robert Weinstein
DFI | Director of Finance/CFO | 64 | 01/13/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 01/18/01 |
Bruce Bernstein
BRD | Director/Board Member | 60 | 14/16/14 |
Joshua Silverman
CHM | Chairman | 53 | 04/16/04 |
Director/Board Member | 50 | 13/18/13 | |
William Singer
BRD | Director/Board Member | 82 | 23/13/23 |
Daniel Alkon
PSD | President | 81 | 07/20/07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,085,333 | 1,058,910 ( 97.57 %) | 0 | 97.57 % |
Stock B | 0 | 6,000 | 0 | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-32.77% | 4.96M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- SNPX Stock
- Company Synaptogenix, Inc.